JPWO2022165247A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022165247A5
JPWO2022165247A5 JP2023546287A JP2023546287A JPWO2022165247A5 JP WO2022165247 A5 JPWO2022165247 A5 JP WO2022165247A5 JP 2023546287 A JP2023546287 A JP 2023546287A JP 2023546287 A JP2023546287 A JP 2023546287A JP WO2022165247 A5 JPWO2022165247 A5 JP WO2022165247A5
Authority
JP
Japan
Prior art keywords
methylation
cancer
sample
markers
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023546287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506854A5 (https=
JP2024506854A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/014408 external-priority patent/WO2022165247A1/en
Publication of JP2024506854A publication Critical patent/JP2024506854A/ja
Publication of JP2024506854A5 publication Critical patent/JP2024506854A5/ja
Publication of JPWO2022165247A5 publication Critical patent/JPWO2022165247A5/ja
Pending legal-status Critical Current

Links

JP2023546287A 2021-01-29 2022-01-28 複数の種類のがんの有無の検出 Pending JP2024506854A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163143611P 2021-01-29 2021-01-29
US63/143,611 2021-01-29
US202163278889P 2021-11-12 2021-11-12
US63/278,889 2021-11-12
PCT/US2022/014408 WO2022165247A1 (en) 2021-01-29 2022-01-28 Detecting the presence or absence of multiple types of cancer

Publications (3)

Publication Number Publication Date
JP2024506854A JP2024506854A (ja) 2024-02-15
JP2024506854A5 JP2024506854A5 (https=) 2025-02-05
JPWO2022165247A5 true JPWO2022165247A5 (https=) 2025-02-05

Family

ID=82613439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023546287A Pending JP2024506854A (ja) 2021-01-29 2022-01-28 複数の種類のがんの有無の検出

Country Status (7)

Country Link
US (1) US20220243278A1 (https=)
EP (1) EP4284951A4 (https=)
JP (1) JP2024506854A (https=)
KR (1) KR20230150814A (https=)
AU (1) AU2022213409A1 (https=)
CA (1) CA3206781A1 (https=)
WO (1) WO2022165247A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
ES2859645T3 (es) 2013-03-14 2021-10-04 Mayo Found Medical Education & Res Detección de neoplasia
EP4234722A3 (en) 2014-03-31 2023-09-20 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
CN107532124B (zh) 2015-03-27 2022-08-09 精密科学公司 检测食管疾病
CN108138235B (zh) 2015-08-31 2022-04-15 梅约医药教育及研究基金会 检测胃肿瘤
AU2016343937B2 (en) 2015-10-30 2023-01-19 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of DNA from plasma
KR102892245B1 (ko) 2017-01-27 2025-11-27 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 메틸화된 dna 분석에 의한 결장 신조직형성의 검출
US10975443B2 (en) 2017-11-30 2021-04-13 Mayo Foundation For Medical Education And Research Detecting breast cancer
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
US12584177B2 (en) 2019-01-24 2026-03-24 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
CA3154354A1 (en) 2019-10-31 2021-05-06 William R. Taylor Detecting ovarian cancer
AU2021409465A1 (en) 2020-12-21 2023-08-03 Freenome Holdings, Inc. Markers for the early detection of colon cell proliferative disorders
CN115725734B (zh) * 2022-08-10 2023-10-13 人和未来生物科技(长沙)有限公司 Znf781基因在制备宫颈癌诊断试剂中的应用
JP2025539812A (ja) * 2022-11-17 2025-12-09 メイヨ ファンデーション フォア メディカル エディケイション アンド リサーチ 泌尿器癌を検出するための組成物及び方法
CN116144773A (zh) * 2022-11-30 2023-05-23 广州康立明生物科技股份有限公司 一种宫颈病变分子诊断试剂
CN116200499B (zh) * 2023-03-23 2024-01-19 北京和瑞精湛医学检验实验室有限公司 一种用于肝癌检测的基因组合与相关试剂和应用
WO2024222519A1 (zh) * 2023-04-26 2024-10-31 博尔诚(北京)科技有限公司 用于检测肝癌的组合物及其用途
WO2025032045A1 (en) * 2023-08-04 2025-02-13 Universiteit Antwerpen Multi-cancer detection assay
CN117310178A (zh) * 2023-09-13 2023-12-29 南通大学 一种用于诊断肝癌预后的生物标志物及其siRNA靶向药物的应用
KR20250081367A (ko) * 2023-11-29 2025-06-05 주식회사 지씨지놈 식도암 및 위암 방사선 치료 반응성 예측용 dna 메틸화 마커 및 이의 용도

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
AU1061395A (en) 1993-11-30 1995-06-19 Mcgill University Inhibition of dna methyltransferase
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6251594B1 (en) 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
EP3048176B1 (en) * 2009-04-20 2019-03-06 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer
WO2011127136A1 (en) 2010-04-06 2011-10-13 University Of Chicago Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc)
US8715937B2 (en) 2010-11-15 2014-05-06 Exact Sciences Corporation Mutation detection assay
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US8808990B2 (en) 2011-05-12 2014-08-19 Exact Sciences Corporation Serial isolation of multiple DNA targets from stool
CN103649298A (zh) 2011-05-12 2014-03-19 精密科学公司 核酸的分离
CA2863215C (en) 2012-01-30 2021-05-04 Exact Sciences Corporation Modification of dna on magnetic beads
US9212392B2 (en) 2012-09-25 2015-12-15 Exact Sciences Corporation Normalization of polymerase activity
EP2922861A4 (en) * 2012-11-26 2016-09-14 Caris Life Sciences Switzerland Holdings Gmbh BIOMARKER COMPOSITIONS AND METHODS
WO2015066695A1 (en) 2013-11-04 2015-05-07 Exact Sciences Corporation Multiple-control calibrators for dna quantitation
CN108138235B (zh) * 2015-08-31 2022-04-15 梅约医药教育及研究基金会 检测胃肿瘤
AU2016343937B2 (en) 2015-10-30 2023-01-19 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of DNA from plasma
US11162139B2 (en) 2016-03-02 2021-11-02 Shanghai Epican Genetech Co. Ltd. Method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine
MX391039B (es) 2016-04-07 2025-03-21 Univ Leland Stanford Junior Diagnostico no invasivo por medio de la secuenciacion del adn libre de celulas 5-hidroxi-metilado.
CN116064796A (zh) * 2016-05-05 2023-05-05 精密科学公司 通过分析甲基化dna来检测肺肿瘤
PL3336197T3 (pl) * 2016-12-16 2022-08-08 Eurofins Genomics Europe Sequencing GmbH Markery epigenetyczne oraz powiązane sposoby i środki wykrywania i leczenia raka jajnika
JP7136899B2 (ja) 2018-01-08 2022-09-13 ルドウイグ インスティテュート フォー キャンサー リサーチ エルティーディー シトシン修飾の、亜硫酸水素塩非含有、塩基分解能特定
CN119753091A (zh) * 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
BR112021009795A2 (pt) * 2018-11-27 2021-08-17 Exact Sciences Development Company, Llc métodos de caracterização e para caracterizar uma amostra, kit e composição
US12584177B2 (en) * 2019-01-24 2026-03-24 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
EP3948292A4 (en) * 2019-04-03 2023-01-18 Mayo Foundation for Medical Education and Research DETECTION OF DUCTAL PANCREATIC CARCINOMA IN PLASMA
GB201908624D0 (en) * 2019-06-17 2019-07-31 Vib Vzw Predicting age using dna methylation signatures

Similar Documents

Publication Publication Date Title
JPWO2022165247A5 (https=)
JP2025114618A5 (https=)
JP2025106467A5 (https=)
Chimonidou et al. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
Rudolph et al. AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
Do Jee et al. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma
Renard et al. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples
Kim et al. Identification of new differentially methylated genes that have potential functional consequences in prostate cancer
ES2829616T3 (es) Procedimiento para la determinación de una mutación en ADN genómico, uso del procedimiento y kit para la realización del procedimiento
Marzese et al. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer
Patai et al. Comprehensive DNA methylation analysis reveals a common ten-gene methylation signature in colorectal adenomas and carcinomas
Borhani et al. Decreased expression of proapoptotic genes caspase-8-and BCL2-associated agonist of cell death (BAD) in ovarian cancer
ES2749514T3 (es) Panel de marcadores genéticos diagnósticos del cáncer colorrectal
Davalos et al. The epigenomic revolution in breast cancer: from single-gene to genome-wide next-generation approaches
CA2713303A1 (en) Utility of b-raf dna mutation in diagnosis and treatment of cancer
JP2021531045A (ja) メチル化修飾に基づく腫瘍マーカーstamp−ep1
EP3828273A1 (en) Methylation modification-based tumor marker stamp-ep2
Taioli et al. Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation
Zhang et al. Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas
Mokarram et al. Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer
Müller et al. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids
Lissa et al. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients
Torng et al. Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma
JP2022516891A (ja) メチル化修飾に基づく腫瘍マーカーstamp-ep6
Gao et al. MALDI‐TOF mass array analysis of Nell-1 promoter methylation patterns in human gastric cancer